About: Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
Creator	Cheng, Liang Chatterjee, Deyali Fiadone, Giulia Il, Jae Kryklyva, Valentyna Luchini, Claudio Malleo, Giuseppe Piredda, Maria Salvia, Roberto Sciammarella, Concetta Wood, Laura
Source	Medline; PMC
abstract	OBJECTIVE: Recently, tumours with microsatellite instability (MSI)/defective DNA mismatch repair (dMMR) have gained considerable interest due to the success of immunotherapy in this molecular setting. Here, we aim to clarify clinical-pathological and/or molecular features of this tumour subgroup through a systematic review coupled with a comparative analysis with existing databases, also providing indications for a correct approach to the clinical identification of MSI/dMMR pancreatic ductal adenocarcinoma (PDAC). DESIGN: PubMed, SCOPUS and Embase were searched for studies reporting data on MSI/dMMR in PDAC up to 30 November 2019. Histological and molecular data of MSI/dMMR PDAC were compared with non-MSI/dMMR PDAC and with PDAC reference cohorts (including SEER database and The Cancer Genome Atlas Research Network - TCGA project). RESULTS: Overall, 34 studies with 8323 patients with PDAC were included in the systematic review. MSI/dMMR demonstrated a very low prevalence in PDAC (around 1%–2%). Compared with conventional PDAC, MSI/dMMR PDAC resulted strongly associated with medullary and mucinous/colloid histology (p<0.01) and with a KRAS/TP53 wild-type molecular background (p<0.01), with more common JAK genes mutations. Data on survival are still unclear. CONCLUSION: PDAC showing typical medullary or mucinous/colloid histology should be routinely examined for MSI/dMMR status using specific tests (immunohistochemistry, followed by MSI-PCR in cases with doubtful results). Next-generation sequencing (NGS) should be adopted either where there is limited tissue or as part of NGS tumour profiling in the context of precision oncology, acknowledging that conventional histology of PDAC may rarely harbour MSI/dMMR.
has issue date	2020-04-29(xsd:dateTime)
bibo:doi	10.1136/gutjnl-2020-320726
bibo:pmid	32350089
has license	cc-by-nc
sha1sum (hex)	f2f3e81f4d92b553f4be13a82aa9b1ed70ba2ebe
schema:url	https://doi.org/10.1136/gutjnl-2020-320726
resource representing a document's title	Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
has PubMed Central identifier	PMC7211065
has PubMed identifier	32350089
schema:publication	Gut
resource representing a document's body	covid:f2f3e81f4d92b553f4be13a82aa9b1ed70ba2ebe#body_text
is schema:about of	named entity 'PCR' named entity 'systematic review' named entity 'KMT2D' named entity 'TMB' named entity 'Fisher's exact test' named entity 'needle biopsy' named entity 'PDAC' named entity 'histology' named entity 'molecular pathology' named entity 'pancreatic ductal adenocarcinoma' named entity 'colorectal cancer' named entity 'PDAC' named entity 'pancreas' named entity 'PDAC' named entity 'systematic review' named entity 'immunotherapy' named entity 'microsatellite' named entity 'systematic review' named entity 'case reports' named entity 'TP53' named entity 'JAK/STAT' named entity 'TMB' named entity 'Microsatellites' named entity 'TMB' named entity 'microsatellite' named entity 'Observational Studies' named entity 'PDAC' named entity 'histological' named entity 'microsatellite instability' named entity 'neoplasms' named entity 'histological' named entity 'microsatellite' named entity 'non-hereditary' named entity 'phase II' named entity 'disease-free survival' named entity 'PDAC' named entity 'IHC' named entity 'PDAC' named entity 'colloid' named entity 'PDAC' named entity 'IPMN' named entity 'Systematic Reviews' named entity '20%' named entity 'FGFR2' named entity 'mucinous' named entity 'wild-type' named entity 'fusion genes' named entity 'IHC' named entity 'NGS' named entity 'Meta-Analysis' named entity 'pancreas' named entity 'microsatellite' named entity 'morphological' named entity 'PDAC' named entity 'NTRK' named entity 'DNA mismatch repair' named entity 'endoscopic ultrasound' named entity 'PDAC' named entity 'KMT2C' named entity 'immunohistochemical' named entity 'PDAC' named entity 'colorectal cancers' named entity 'EBV' named entity 'IHC' named entity 'heterogeneity' named entity 'molecular data' named entity 'PDAC' named entity 'SCOPUS' named entity 'KMT2D' named entity 'colloid' named entity 'germline mutations'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software